Most GHK-Cu copper peptides are administered via subcutaneous injection
PMID: [PMC free article] [PubMed] [Google Scholar] 16.Gallagher RM, Kunkel R
incidence rates were 1% of adult patients
Common user-reported outcomes include: Faster recovery timelines from tendon and ligament injuries (e.g., sprains, tears, tendinitis) Reduced joint pain and inflammation , especially in chronic overuse cases Improved mobility and function , even after prolonged downtime Noticeable benefits when combined with physical therapy or structured rehab protocols Many report using BPC-157 alongside TB500 for a synergistic approach to healing dense connective tissues , especially when muscle, tendon, and fascia are involved
It improves adherence, which directly improves outcomes
Hong DS, Patel JC, Wheler J, Naing A, Garrido-Laguna I, Falchook G, Fu S, Tsimberidou AM, Kopetz ES , Win S, Kurzrock R